UNC School of Medicine Leads $9.3-Million Study to Create Chlamydia Vaccine
May 22, 2024
May 22, 2024
CHAPEL HILL, North Carolina, May 22 (TNSres) -- The University of North Carolina School of Medicine issued the following news release:
To address the global epidemic of sexually transmitted diseases, the National Institute of Allergy and Infectious Diseases has awarded a five-year, $9.3 million grant to the University of North Carolina at Chapel Hill, Vaxcyte, and the University of Chicago to develop a vaccine candidate for the prevention of Chlamydia.
Through this sign . . .
To address the global epidemic of sexually transmitted diseases, the National Institute of Allergy and Infectious Diseases has awarded a five-year, $9.3 million grant to the University of North Carolina at Chapel Hill, Vaxcyte, and the University of Chicago to develop a vaccine candidate for the prevention of Chlamydia.
Through this sign . . .